Apollon Formularies Plc Notice of AGM
05 Décembre 2023 - 12:59PM
UK Regulatory
TIDMAPOL
05 December 2023
Apollon Formularies Plc
("Apollon" or the "Company")
Notice of AGM
Apollon Formularies plc (AQSE: APOL) announces that notice of its Annual General
Meeting ('AGM') has been posted to shareholders, and will shortly be available
at the Company website on https://www.apollon.org.uk/. The AGM will be held on
29 December 2023 at 11am, at 6 Heddon Street, London W1B 4BT.
The directors of the Company accept responsibility for the contents of this
announcement.
ENDS
For additional information, please visit www.apollon.org.uk or contact:
Apollon Formularies
Tel: +44 771 198 0221
Stene Jacobs stene@apollon.org.uk
Peterhouse Capital Limited (Corporate Adviser)
Tel: +44 207 220 9795
Guy Miller gm@peterhousecapital.com
About Apollon and Apollon Jamaica
Apollon Formularies plc is an international medical cannabis and medicinal
mushroom pharmaceutical company headquartered in the United Kingdom. Apollon
Formularies Jamaica Limited is a pharmaceutical company incorporated and
operating in the Commonwealth of Jamaica since 2016. Apollon Jamaica is licensed
by the Jamaican government's Cannabis Licensing Authority (CLA) to cultivate
(R&D), perform research and development, process, and sell medical cannabis
therapeutic products that include legal medical cannabis to treat various
illnesses under medical supervision.
This information was brought to you by Cision http://news.cision.com
END
(END) Dow Jones Newswires
December 05, 2023 06:59 ET (11:59 GMT)
Apollon Formularies (AQSE:APOL)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Apollon Formularies (AQSE:APOL)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024